WC
BTMDW

Wealthspring Capital’s Biote Corp. Warrant BTMDW Stock Holding History

Wealthspring Capital’s Portfolio BTMDW Stock Details BTMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-51,736
Closed -$28K – 495
2022
Q1 		$28K Buy
+51,736
New +$24.5K 0.01% 428

Other funds holding BTMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
SRF
Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

Wealthspring Capital's BTMDW Position: Q2 2022 in Review

Wealthspring Capital sold out of Biote Corp. Warrant (BTMDW) in Q2 2022, closing a stake of 51,736 shares — an estimated $28K sold.

Wealthspring Capital first reported a position in BTMDW in Q1 2022 and held it in 1 quarter. The position peaked at $28K in Q1 2022. 42 funds tracked by Wall St. Rank hold BTMDW as of Q2 2022.

  • Wealthspring Capital reported no remaining Biote Corp. Warrant position as of Q2 2022 after selling out during the quarter.
  • Wealthspring Capital sold 51,736 Biote Corp. Warrant shares in Q2 2022, an estimated $28K.
  • Wealthspring Capital first reported a position in Biote Corp. Warrant in Q1 2022 and held it in 1 quarter.
  • Wealthspring Capital's Biote Corp. Warrant position peaked at $28K in Q1 2022.
  • 42 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q2 2022.

Based on Wealthspring Capital's 13F filing for Q2 2022, filed 22 Jul 2022.